Aravax

Aravax is a biotechnology company focused on developing drugs for the treatment of food allergies. Aravax applies proprietary technology to design targeted drug therapies that can reset the immune system to tolerate specific allergens without triggering allergic reactions during treatment. The main product, PVX108, is a novel antigen-specific immunomodulatory agent used for treating peanut allergy in children.